The technique developed by 1NA, combined with fluorescence microscopy, provides high-throughput data of proteins interacting with DNA. Our group is focusing on mitochondrial dysfunctions, where this technique will be our tool of choice for screening drugs targeting the mitochondrial replication machinery.